TapewireFind a company

person · Reporting owner

Russell Erin L

Disclosed activity across 5 companies

Tapewire entity
32390
SEC CIK
0001488754

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Fortrea Holdings Inc.FTRE · Entity 4623DirectorJune 10, 2026June 12, 2026
KADANT INCKAI · Entity 4135DirectorOctober 03, 2026October 05, 2026
ModivCare IncMODV · Entity 76927DirectorFebruary 10, 2025February 14, 2025
eHealth, Inc.EHTH · Entity 497DirectorJune 18, 2026June 23, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Fortrea Holdings Inc.

Report date June 10, 2026 · Filed June 12, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect72,617 Reported balance After 2026-06-10 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-06-10 · Exercise / conversion · Acquired 38,817 · Balance 72,617

F1: Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of Fortrea Holdings Inc. ("Fortrea") common stock ("Common Stock"). This transaction represents the settlement of RSUs into Common Stock on their scheduled vesting date.

F2: This number reflects the aggregate amount of Common Stock held by the reporting person.

Restricted Stock UnitSEC Table II · derivative / convertible securityDirect0 Reported balance After 2026-06-10 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-06-10 · Exercise / conversion · Disposed 38,817 · Balance 0

F1: Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of Fortrea Holdings Inc. ("Fortrea") common stock ("Common Stock"). This transaction represents the settlement of RSUs into Common Stock on their scheduled vesting date.

F3: Represents a RSU award that vested in its entirety on June 10, 2026.

Restricted Stock UnitSEC Table II · derivative / convertible securityDirect12,852 Reported balance After 2026-06-10 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-06-10 · Grant · Acquired 12,852 · Balance 12,852

F4: Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of Fortrea Holdings Inc. ("Fortrea") common stock ("Common Stock").

F5: Represents a RSU award that vests in its entirety twelve months after June 10, 2026, subject to the Reporting Person's continued service as a director.

F6: This number reflects the aggregate number of RSUs held by the reporting person.

Filing footnotes · ownership attribution and instrument terms

F1: Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of Fortrea Holdings Inc. ("Fortrea") common stock ("Common Stock"). This transaction represents the settlement of RSUs into Common Stock on their scheduled vesting date.

F2: This number reflects the aggregate amount of Common Stock held by the reporting person.

F3: Represents a RSU award that vested in its entirety on June 10, 2026.

F4: Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of Fortrea Holdings Inc. ("Fortrea") common stock ("Common Stock").

F5: Represents a RSU award that vests in its entirety twelve months after June 10, 2026, subject to the Reporting Person's continued service as a director.

F6: This number reflects the aggregate number of RSUs held by the reporting person.

KADANT INC

Report date October 03, 2026 · Filed October 05, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect3,582 Reported balance After 2026-10-03 transaction · row 1
1 source row

Row 1 · 2026-10-03 · Exercise / conversion · Acquired 128 · Balance 3,582

F1: Represents partial vesting of a restricted stock unit award on October 3, 2026 and delivery of shares of the reporting person pursuant to the terms of a restricted stock unit award agreement dated March 11, 2026. The remainder of the shares vest on the last day of the Issuer's fourth quarter in fiscal 2026 provided the recipient continues to serve as a director of the Issuer.

Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-01-31Direct128 Reported balance After 2026-10-03 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-10-03 · Exercise / conversion · Disposed 128 · Balance 128

F1: Represents partial vesting of a restricted stock unit award on October 3, 2026 and delivery of shares of the reporting person pursuant to the terms of a restricted stock unit award agreement dated March 11, 2026. The remainder of the shares vest on the last day of the Issuer's fourth quarter in fiscal 2026 provided the recipient continues to serve as a director of the Issuer.

Filing footnotes · ownership attribution and instrument terms

F1: Represents partial vesting of a restricted stock unit award on October 3, 2026 and delivery of shares of the reporting person pursuant to the terms of a restricted stock unit award agreement dated March 11, 2026. The remainder of the shares vest on the last day of the Issuer's fourth quarter in fiscal 2026 provided the recipient continues to serve as a director of the Issuer.

ModivCare Inc

Report date February 10, 2025 · Filed February 14, 2025

This filing explicitly reported no securities owned.

eHealth, Inc.

Report date June 18, 2026 · Filed June 23, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect176,078 Reported balance After 2026-06-18 transaction · row 1
1 source row

Row 1 · 2026-06-18 · Grant · Acquired 61,041 · Balance 176,078

F1: This represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs vest in four equal quarterly installments from the vesting commencement date of June 18, 2026, subject to the individual's continued status as a Service Provider (as defined in the Issuer's Amended and Restated 2024 Equity Incentive Plan (the "Plan")) through the applicable vesting date; provided, however, that any then-unvested RSUs shall vest in full (i) on the day immediately prior to the date of the Issuer's next annual stockholder meeting or (ii) if the Issuer is subject to a Change in Control (as defined in the Plan), subject in each case to the individual's continued status as a Service Provider through such vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: This represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs vest in four equal quarterly installments from the vesting commencement date of June 18, 2026, subject to the individual's continued status as a Service Provider (as defined in the Issuer's Amended and Restated 2024 Equity Incentive Plan (the "Plan")) through the applicable vesting date; provided, however, that any then-unvested RSUs shall vest in full (i) on the day immediately prior to the date of the Issuer's next annual stockholder meeting or (ii) if the Issuer is subject to a Change in Control (as defined in the Plan), subject in each case to the individual's continued status as a Service Provider through such vesting date.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

TIVITY HEALTH, INC.

Report date June 28, 2022 · Filed June 29, 2022

Section 16 reporting ended · disclosed 2022-06-29. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2022-06-28 transaction · row 1
1 source row

Row 1 · 2022-06-28 · Disposition to issuer · Disposed 31,245 · Balance 0

F1: Pursuant to the Agreement and Plan of Merger, dated as of April 5, 2022 (the "Merger Agreement"), by and among Tivity Health OpCo Parent, Inc. (f/k/a Titan-Atlas Parent, Inc.), a Delaware corporation ("Parent"), Titan-Atlas Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Parent ("Merger Sub"), and Tivity Health, Inc. (the "Company"), each share of common stock, par value $0.001 per share, of the Company ("Company Common Stock") was converted into the right to receive a cash payment (without interest and subject to any applicable taxes) equal to the per share merger consideration of $32.50.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger, dated as of April 5, 2022 (the "Merger Agreement"), by and among Tivity Health OpCo Parent, Inc. (f/k/a Titan-Atlas Parent, Inc.), a Delaware corporation ("Parent"), Titan-Atlas Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Parent ("Merger Sub"), and Tivity Health, Inc. (the "Company"), each share of common stock, par value $0.001 per share, of the Company ("Company Common Stock") was converted into the right to receive a cash payment (without interest and subject to any applicable taxes) equal to the per share merger consideration of $32.50.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 01, 2022 Filed Jun 1, 2022 20:10 UTC KADANT INC KAI · Entity 4135 Exercise / conversionCommon Stock 471 Not disclosed Not disclosed
Disclosure

SEC source: 0000886346-22-000117 · wf-form4_165411419677978.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,523

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents partial vesting of a restricted stock unit award on June 1, 2022 and delivery of shares to the reporting person pursuant to the terms of a restricted stock unit award agreement dated May 18, 2022. The remainder of the shares vest in two equal installments on the last day of each of the Issuer's third and fourth quarters of fiscal 2022 provided the recipient continues to serve as a director of the Issuer.

Read SEC document
May 18, 2022 Filed May 20, 2022 20:17 UTC KADANT INC KAI · Entity 4135 GrantRestricted Stock Unit · Derivative 941 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000886346-22-000106 · wf-form4_165307783135335.xml · derivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 941

Underlying: Common Stock · 941 shares

Expires 2023-01-31

F1 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock. 50% of the RSU vests on June 1, 2022 and the remainder vests in two equal installments on the last day of each of the Issuer's third and fourth quarters of fiscal 2022 provided the recipient continues to serve as a director of the Issuer.

Read SEC document
March 31, 2022 Filed Apr 1, 2022 14:37 UTC TIVITY HEALTH, INC. TVTY · Entity 125776 GrantCommon Stock 612 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-007825 · doc1.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,245

F1 · shares: Reflects fully vested shares of common stock issued pursuant to the Tivity Health, Inc. Director Deferred Compensation Program, in lieu of an elected portion of the cash retainer fees earned for the director's service on the issuer's Board of Directors. The number of shares of common stock acquired was calculated by dividing the elected portion of the deferred cash retainer amount by the closing price of the issuer's common stock on the date the cash retainer was payable.

Read SEC document
January 01, 2022 Filed Jan 3, 2022 21:34 UTC KADANT INC KAI · Entity 4135 Exercise / conversionRestricted Stock Unit · Derivative 252 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000886346-22-000010 · wf-form4_164124563593080.xml · derivative · entry 2

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 252 shares

Expires 2022-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Represents partial vesting of a restricted stock unit award on January 1, 2022 and delivery of shares to the reporting person pursuant to the terms of a restricted stock unit award agreement dated May 19, 2021.

Read SEC document
January 01, 2022 Filed Jan 3, 2022 21:34 UTC KADANT INC KAI · Entity 4135 Exercise / conversionCommon Stock 252 Not disclosed Not disclosed
Disclosure

SEC source: 0000886346-22-000010 · wf-form4_164124563593080.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,052

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents partial vesting of a restricted stock unit award on January 1, 2022 and delivery of shares to the reporting person pursuant to the terms of a restricted stock unit award agreement dated May 19, 2021.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 17:53 UTC TIVITY HEALTH, INC. TVTY · Entity 125776 GrantCommon Stock 745 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-000321 · doc1.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,633

F1 · shares: Reflects fully vested shares of common stock issued pursuant to the Tivity Health, Inc. Director Deferred Compensation Program, in lieu of an elected portion of the cash retainer fees earned for the director's service on the issuer's Board of Directors. The number of shares of common stock acquired was calculated by dividing the elected portion of the deferred cash retainer amount by the closing price of the issuer's common stock on the date the cash retainer was payable.

Read SEC document
November 12, 2021 Filed Nov 15, 2021 21:41 UTC eHealth, Inc. EHTH · Entity 497 PurchaseCommon Stock 3,556 $28.12 $99,997.92
Disclosure

SEC source: 0001333493-21-000175 · wf-form4_163701243992451.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,697

F1 · price: The price reported in Table I, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $28.12 to $28.13. The reporting person undertakes to provide to eHealth, Inc., any security holder of eHealth, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price with the range set forth in this footnote.

Read SEC document
October 02, 2021 Filed Oct 4, 2021 20:18 UTC KADANT INC KAI · Entity 4135 Exercise / conversionRestricted Stock Unit · Derivative 252 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000886346-21-000130 · wf-form4_163337866098085.xml · derivative · entry 2

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 252

Underlying: Common Stock · 252 shares

Expires 2022-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Represents partial vesting of a restricted stock unit award on October 2, 2021 and delivery of shares to the reporting person pursuant to the terms of a restricted stock unit award agreement dated May 19, 2021. The remainder of the shares vest on the last day of of the Issuer's fourth quarter of fiscal 2021 provided the recipient continues to serve as a director of the Issuer.

Read SEC document
October 02, 2021 Filed Oct 4, 2021 20:18 UTC KADANT INC KAI · Entity 4135 Exercise / conversionCommon Stock 252 Not disclosed Not disclosed
Disclosure

SEC source: 0000886346-21-000130 · wf-form4_163337866098085.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,800

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents partial vesting of a restricted stock unit award on October 2, 2021 and delivery of shares to the reporting person pursuant to the terms of a restricted stock unit award agreement dated May 19, 2021. The remainder of the shares vest on the last day of of the Issuer's fourth quarter of fiscal 2021 provided the recipient continues to serve as a director of the Issuer.

Read SEC document
September 30, 2021 Filed Oct 4, 2021 15:18 UTC TIVITY HEALTH, INC. TVTY · Entity 125776 GrantCommon Stock 854 $23.06 $19,693.24
Disclosure

SEC source: 0001567619-21-017801 · doc1.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,888

F1 · shares: Reflects fully vested shares of common stock issued pursuant to the Tivity Health, Inc. Director Deferred Compensation Program, in lieu of an elected portion of the cash retainer fees earned for the director's service on the issuer's Board of Directors. The number of shares of common stock acquired was calculated by dividing the elected portion of the deferred cash retainer amount by the closing price of the issuer's common stock on the date the cash retainer was payable.

Read SEC document
September 30, 2021 Filed Apr 1, 2022 14:40 UTC Amendment TIVITY HEALTH, INC. TVTY · Entity 125776 GrantCommon Stock 854 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-007827 · doc1.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,888

F1 · shares: Reflects fully vested shares of common stock issued pursuant to the Tivity Health, Inc. Director Deferred Compensation Program, in lieu of an elected portion of the cash retainer fees earned for the director's service on the issuer's Board of Directors. The number of shares of common stock acquired was calculated by dividing the elected portion of the deferred cash retainer amount by the closing price of the issuer's common stock on the date the cash retainer was payable.

F2 · price: This amendment is being filed solely to reflect a price of $0 for the reported transaction, which corrects an administrative error in the original Form 4.

Read SEC document
July 21, 2021 Filed Jul 23, 2021 18:27 UTC eHealth, Inc. EHTH · Entity 497 GrantCommon Stock 3,374 $0.00 $0.00
Disclosure

SEC source: 0001333493-21-000127 · wf-form4_162706484874729.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,141

F1 · kind: This represents an initial award of restricted stock units. Each unit represents a contingent right to receive one share of the company's common stock upon vesting. The restricted stock units are scheduled to vest in four equal annual installments from the vesting commencement date of July 21, 2021, subject to the individual continuing to provide services to the company through the applicable vesting date.

Read SEC document
June 30, 2021 Filed Jul 1, 2021 16:25 UTC TIVITY HEALTH, INC. TVTY · Entity 125776 GrantCommon Stock 748 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-012843 · doc1.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,034

F1 · shares: Reflects fully vested shares of common stock issued pursuant to the Tivity Health, Inc. Director Deferred Compensation Program, in lieu of an elected portion of the cash retainer fees earned for the director's service on the issuer's Board of Directors. The number of shares of common stock acquired was calculated by dividing the elected portion of the deferred cash retainer amount by the closing price of the issuer's common stock on the date the cash retainer was payable.

Read SEC document
June 24, 2021 Filed Jun 24, 2021 20:41 UTC KADANT INC KAI · Entity 4135 SaleCommon Stock 450 $180.00 $81,000.00
Disclosure

SEC source: 0000886346-21-000108 · wf-form4_162456727841943.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,548

F1 · kind: The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted March 8, 2021.

Read SEC document
June 01, 2021 Filed Jun 1, 2021 20:15 UTC KADANT INC KAI · Entity 4135 Exercise / conversionRestricted Stock Unit · Derivative 505 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000886346-21-000092 · wf-form4_162257851538510.xml · derivative · entry 2

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 504

Underlying: Common Stock · 505 shares

Expires 2022-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Represents partial vesting of a restricted stock unit award on June 1, 2021 and delivery of shares to the reporting person pursuant to the terms of a restricted stock unit award agreement dated May 19, 2021. The remainder of the shares vest in two equal installments on the last day of each of the Issuer's third and fourth quarters of fiscal 2021 provided the recipient continues to serve as a director of the Issuer.

Read SEC document
June 01, 2021 Filed Jun 1, 2021 20:15 UTC KADANT INC KAI · Entity 4135 Exercise / conversionCommon Stock 505 Not disclosed Not disclosed
Disclosure

SEC source: 0000886346-21-000092 · wf-form4_162257851538510.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,998

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents partial vesting of a restricted stock unit award on June 1, 2021 and delivery of shares to the reporting person pursuant to the terms of a restricted stock unit award agreement dated May 19, 2021. The remainder of the shares vest in two equal installments on the last day of each of the Issuer's third and fourth quarters of fiscal 2021 provided the recipient continues to serve as a director of the Issuer.

Read SEC document
May 20, 2021 Filed May 21, 2021 14:27 UTC TIVITY HEALTH, INC. TVTY · Entity 125776 GrantCommon Stock 5,048 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-010879 · doc1.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,286

F1 · shares: Reflects restricted stock units that vest on the earlier of (i) the first anniversary of the Grant Date (such Grant Date being 5/20/2021), or (ii) the first annual meeting of the stockholders of Tivity Health that occurs after the Grant Date.

Read SEC document
May 19, 2021 Filed May 21, 2021 20:15 UTC KADANT INC KAI · Entity 4135 GrantRestricted Stock Unit · Derivative 1,009 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000886346-21-000082 · wf-form4_162162812806381.xml · derivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,009

Underlying: Common Stock · 1,009 shares

Expires 2022-01-31

F1 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock. 50% of the RSU vests on June 1, 2021 and the remainder vests in two equal installments on the last day of each of the Issuer's third and fourth quarters of fiscal 2021 provided the recipient continues to serve as a director of the Issuer.

Read SEC document
May 17, 2021 Filed May 17, 2021 20:18 UTC KADANT INC KAI · Entity 4135 SaleCommon Stock 201 $174.15 $35,004.69
Disclosure

SEC source: 0000886346-21-000069 · wf-form4_162128268194725.xml · nonDerivative · entry 2

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,493

F1 · kind: The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted March 8, 2021.

F3 · price: Represents the weighted average sale price. The actual sales prices range from $172.6875 to $174.16 per share. The reporting person will supply the SEC, the Issuer, or a security holder of the Issuer, with full information regarding the number of shares at each price upon request.

Read SEC document
May 17, 2021 Filed May 17, 2021 20:18 UTC KADANT INC KAI · Entity 4135 SaleCommon Stock 249 $171.96 $42,817.94
Disclosure

SEC source: 0000886346-21-000069 · wf-form4_162128268194725.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,694

F1 · kind: The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted March 8, 2021.

F2 · price: Represents the weighted average sale price. The actual sales prices range from $171.55 to $172.52 per share. The reporting person will supply the SEC, the Issuer, or a security holder of the Issuer, with full information regarding the number of shares at each price upon request.

Read SEC document
March 31, 2021 Filed Apr 1, 2021 16:23 UTC TIVITY HEALTH, INC. TVTY · Entity 125776 GrantCommon Stock 882 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-007379 · doc1.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,238

F1 · shares: Reflects fully vested shares of common stock issued pursuant to the Tivity Health, Inc. Director Deferred Compensation Program, in lieu of an elected portion of the cash retainer fees earned for the director's service on the issuer's Board of Directors. The number of shares of common stock acquired was calculated by dividing the elected portion of the deferred cash retainer amount by the closing price of the issuer's common stock on the date the cash retainer was payable.

Read SEC document
January 02, 2021 Filed Jan 4, 2021 21:13 UTC KADANT INC KAI · Entity 4135 Exercise / conversionRestricted Stock Unit · Derivative 521 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000886346-21-000010 · wf-form4_160979482495175.xml · derivative · entry 2

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 521 shares

Expires 2021-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Represents partial vesting of a restricted stock unit award on January 2, 2021 and delivery of shares to the reporting person pursuant to the terms of a restricted stock unit award agreement dated May 12, 2020.

Read SEC document
January 02, 2021 Filed Jan 4, 2021 21:13 UTC KADANT INC KAI · Entity 4135 Exercise / conversionCommon Stock 521 Not disclosed Not disclosed
Disclosure

SEC source: 0000886346-21-000010 · wf-form4_160979482495175.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,943

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents partial vesting of a restricted stock unit award on January 2, 2021 and delivery of shares to the reporting person pursuant to the terms of a restricted stock unit award agreement dated May 12, 2020.

Read SEC document
September 26, 2020 Filed Sep 29, 2020 20:19 UTC KADANT INC KAI · Entity 4135 Exercise / conversionRestricted Stock Unit · Derivative 521 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000886346-20-000127 · wf-form4_160141072941978.xml · derivative · entry 2

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 521

Underlying: Common Stock · 521 shares

Expires 2021-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Represents partial vesting of a restricted stock unit award on September 26, 2020 and delivery of shares to the reporting person pursuant to the terms of a restricted stock unit award agreement dated May 12, 2020. The remainder of the shares vest on the last day of of the Issuer's fourth quarter of fiscal 2020 provided the recipient continues to serve as a director of the Issuer.

Read SEC document
September 26, 2020 Filed Sep 29, 2020 20:19 UTC KADANT INC KAI · Entity 4135 Exercise / conversionCommon Stock 521 Not disclosed Not disclosed
Disclosure

SEC source: 0000886346-20-000127 · wf-form4_160141072941978.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,422

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents partial vesting of a restricted stock unit award on September 26, 2020 and delivery of shares to the reporting person pursuant to the terms of a restricted stock unit award agreement dated May 12, 2020. The remainder of the shares vest on the last day of of the Issuer's fourth quarter of fiscal 2020 provided the recipient continues to serve as a director of the Issuer.

Read SEC document
August 24, 2020 Filed Aug 25, 2020 15:30 UTC TIVITY HEALTH, INC. TVTY · Entity 125776 GrantCommon Stock 2,125 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-015957 · doc1.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,356

F1 · shares: Reflects restricted stock units that vest in full on August 24, 2021.

Read SEC document
June 01, 2020 Filed Jun 1, 2020 20:41 UTC KADANT INC KAI · Entity 4135 Exercise / conversionRestricted Stock Unit · Derivative 1,043 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000886346-20-000095 · wf-form4_159104406311051.xml · derivative · entry 2

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,042

Underlying: Common Stock · 1,043 shares

Expires 2021-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Represents partial vesting of a restricted stock unit award on June 1, 2020 and delivery of shares to the reporting person pursuant to the terms of a restricted stock unit award agreement dated May 12, 2020. The remainder of the shares vest in two equal installments on the last day of each of the Issuer's third and fourth quarters of fiscal 2020 provided the recipient continues to serve as a director of the Issuer.

Read SEC document
June 01, 2020 Filed Jun 1, 2020 20:41 UTC KADANT INC KAI · Entity 4135 Exercise / conversionCommon Stock 1,043 Not disclosed Not disclosed
Disclosure

SEC source: 0000886346-20-000095 · wf-form4_159104406311051.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,901

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents partial vesting of a restricted stock unit award on June 1, 2020 and delivery of shares to the reporting person pursuant to the terms of a restricted stock unit award agreement dated May 12, 2020. The remainder of the shares vest in two equal installments on the last day of each of the Issuer's third and fourth quarters of fiscal 2020 provided the recipient continues to serve as a director of the Issuer.

Read SEC document
May 21, 2020 Filed May 26, 2020 13:57 UTC TIVITY HEALTH, INC. TVTY · Entity 125776 GrantCommon Stock 10,827 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-011134 · doc1.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,231

F1 · shares: Reflects restricted stock units that vest on the earlier of (i) the first anniversary of the Grant Date (such Grant Date being 5/21/2020), or (ii) the first annual meeting of the stockholders of Tivity Health that occurs after the Grant Date.

Read SEC document
May 12, 2020 Filed May 14, 2020 12:30 UTC KADANT INC KAI · Entity 4135 GrantRestricted Stock Unit · Derivative 2,085 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000886346-20-000075 · wf-form4_158945943874970.xml · derivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,085

Underlying: Common Stock · 2,085 shares

Expires 2021-01-31

F1 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock. 50% of the RSU vests on June 1, 2020 and the remainder vests in two equal installments on the last day of each of the Issuer's third and fourth quarters of fiscal 2020 provided the recipient continues to serve as a director of the Issuer.

Read SEC document
May 11, 2020 Filed May 13, 2020 17:08 UTC TIVITY HEALTH, INC. TVTY · Entity 125776 GrantCommon Stock 3,602 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-009838 · doc1.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,404

F1 · shares: Reflects restricted stock units that vest in full on May 11, 2021.

Read SEC document
March 16, 2020 Filed Mar 18, 2020 12:05 UTC TIVITY HEALTH, INC. TVTY · Entity 125776 GrantCommon Stock 5,802 $0.00 $0.00
Disclosure

SEC source: 0001567619-20-006655 · doc1.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,802

F1 · shares: Reflects restricted stock units that vest in full on March 16, 2021.

Read SEC document
December 28, 2019 Filed Dec 30, 2019 13:57 UTC KADANT INC KAI · Entity 4135 Exercise / conversionRestricted Stock Unit · Derivative 464 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000886346-19-000177 · wf-form4_157771421473179.xml · derivative · entry 2

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 464 shares

Expires 2020-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Represents partial vesting of a restricted stock unit award on December 28, 2019 and delivery of shares to the reporting person pursuant to the terms of a restricted stock unit award agreement dated May 16, 2019.

Read SEC document
December 28, 2019 Filed Dec 30, 2019 13:57 UTC KADANT INC KAI · Entity 4135 Exercise / conversionCommon Stock 464 Not disclosed Not disclosed
Disclosure

SEC source: 0000886346-19-000177 · wf-form4_157771421473179.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,858

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents partial vesting of a restricted stock unit award on December 28, 2019 and delivery of shares to the reporting person pursuant to the terms of a restricted stock unit award agreement dated May 16, 2019.

Read SEC document
September 28, 2019 Filed Sep 30, 2019 13:03 UTC KADANT INC KAI · Entity 4135 Exercise / conversionRestricted Stock Unit · Derivative 465 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000886346-19-000130 · wf-form4_156984861658955.xml · derivative · entry 2

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 464

Underlying: Common Stock · 465 shares

Expires 2020-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Represents partial vesting of a restricted stock unit award on September 28, 2019 and delivery of shares to the reporting person pursuant to the terms of a restricted stock unit award agreement dated May 16, 2019. The remainder of the shares vest on the last day of of the Issuer's fourth quarter of fiscal 2019 provided the recipient continues to serve as a director of the Issuer.

Read SEC document
September 28, 2019 Filed Sep 30, 2019 13:03 UTC KADANT INC KAI · Entity 4135 Exercise / conversionCommon Stock 465 Not disclosed Not disclosed
Disclosure

SEC source: 0000886346-19-000130 · wf-form4_156984861658955.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,394

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents partial vesting of a restricted stock unit award on September 28, 2019 and delivery of shares to the reporting person pursuant to the terms of a restricted stock unit award agreement dated May 16, 2019. The remainder of the shares vest on the last day of of the Issuer's fourth quarter of fiscal 2019 provided the recipient continues to serve as a director of the Issuer.

Read SEC document
June 01, 2019 Filed Jun 3, 2019 12:46 UTC KADANT INC KAI · Entity 4135 Exercise / conversionRestricted Stock Unit · Derivative 929 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000886346-19-000095 · wf-form4_155956597686852.xml · derivative · entry 2

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 929

Underlying: Common Stock · 929 shares

Expires 2020-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents partial vesting of a restricted stock unit award on June 1, 2019 and delivery of shares to the reporting person pursuant to the terms of a restricted stock unit award agreement dated May 16, 2019. The remainder of the shares vest in two equal installments on the last day of each of the Issuer's third and fourth quarters of fiscal 2019 provided the recipient continues to serve as a director of the Issuer.

F1 · derivative.exercise_date: Represents partial vesting of a restricted stock unit award on June 1, 2019 and delivery of shares to the reporting person pursuant to the terms of a restricted stock unit award agreement dated May 16, 2019. The remainder of the shares vest in two equal installments on the last day of each of the Issuer's third and fourth quarters of fiscal 2019 provided the recipient continues to serve as a director of the Issuer.

F1 · derivative.expiration_date: Represents partial vesting of a restricted stock unit award on June 1, 2019 and delivery of shares to the reporting person pursuant to the terms of a restricted stock unit award agreement dated May 16, 2019. The remainder of the shares vest in two equal installments on the last day of each of the Issuer's third and fourth quarters of fiscal 2019 provided the recipient continues to serve as a director of the Issuer.

F1 · derivative.underlying_shares: Represents partial vesting of a restricted stock unit award on June 1, 2019 and delivery of shares to the reporting person pursuant to the terms of a restricted stock unit award agreement dated May 16, 2019. The remainder of the shares vest in two equal installments on the last day of each of the Issuer's third and fourth quarters of fiscal 2019 provided the recipient continues to serve as a director of the Issuer.

Read SEC document
June 01, 2019 Filed Jun 3, 2019 12:46 UTC KADANT INC KAI · Entity 4135 Exercise / conversionCommon Stock 929 Not disclosed Not disclosed
Disclosure

SEC source: 0000886346-19-000095 · wf-form4_155956597686852.xml · nonDerivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 929

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents partial vesting of a restricted stock unit award on June 1, 2019 and delivery of shares to the reporting person pursuant to the terms of a restricted stock unit award agreement dated May 16, 2019. The remainder of the shares vest in two equal installments on the last day of each of the Issuer's third and fourth quarters of fiscal 2019 provided the recipient continues to serve as a director of the Issuer.

Read SEC document
May 16, 2019 Filed May 17, 2019 20:40 UTC KADANT INC KAI · Entity 4135 GrantRestricted Stock Unit · Derivative 1,858 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000886346-19-000081 · wf-form4_155812562840501.xml · derivative · entry 1

Russell Erin L · CIK 0001488754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,858

Underlying: Common Stock · 1,858 shares

Expires 2020-01-31

F1 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock. 50% of the RSU vests on June 1, 2019 and the remainder vests in two equal installments on the last day of each of the Issuer's third and fourth quarters of fiscal 2019 provided the recipient continues to serve as a director of the Issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.